NCT05441215View on ClinicalTrials.gov

A Study to Learn About the Medicine (PF-07321332 or Nirmatrelvir/Ritonavir) in Healthy Lactating Women

PHASE1CompletedINTERVENTIONAL

Enrollment

8

Participants

Timeline

Start Date

December 12, 2022

Primary Completion Date

December 15, 2023

Study Completion Date

December 15, 2023

Conditions

Healthy Participants

Interventions

DRUG

nirmatrelvir

nirmatrelvir/ritonavir

DRUG

ritonavir

nirmatrelvir/ritonavir

Trial Locations (1)

B-1070

Pfizer Clinical Research Unit - Brussels, Brussels

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY